Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal and geographic analyses of colorectal cancer screening during and after the COVID-19 pandemic in a federally qualified health center.

PloS one·2026
Same author

Projected Demographic Trends in the Likelihood of Having or Becoming a Dementia Family Caregiver in the U.S. Through 2060.

Populations·2026
Same author

CRC-SPIN version 3.0: an updated policy model for colorectal cancer screening that includes the serrated pathway.

Journal of the National Cancer Institute·2026
Same author

Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screening.

Journal of the National Cancer Institute·2026
Same author

Correction: Community-based participatory design of a decade: the FAITH! Cardiovascular Health and Wellness Program.

Frontiers in public health·2026
Same author

Discrete-Event Simulation Modeling Framework for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline.

PharmacoEconomics·2026

Related Experiment Video

Updated: May 12, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

Measurement in comparative effectiveness research.

Jessica Chubak1, Carolyn M Rutter, Aruna Kamineni

  • 1Group Health Research Institute, Seattle, WA 98101, USA. chubak.j@ghc.org

American Journal of Preventive Medicine
|April 20, 2013
PubMed
Summary
This summary is machine-generated.

Comparative effectiveness research (CER) defines measures for preventive services. Understanding relative effectiveness of regimens and programs is crucial for healthcare decisions and policy development.

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Experiment Videos

Last Updated: May 12, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

  • Health Services Research
  • Preventive Medicine
  • Health Policy Analysis

Background:

  • Comparative effectiveness research (CER) informs policy and clinical decisions for disease prevention.
  • Patients, providers, and policymakers require clear information on the relative effectiveness of preventive services.
  • Existing measures may not adequately differentiate between individual regimens and population-wide programs.

Purpose of the Study:

  • To define and differentiate measures of relative effectiveness for disease prevention regimens and programs.
  • To clarify the distinct scientific and policy questions addressed by regimen vs. program effectiveness measures.
  • To establish a common lexicon for CER measures in preventive services.

Main Methods:

  • Conceptual and algebraic definitions of relative effectiveness measures.
  • Illustrative examples using hypothetical cancer screening regimens and programs.
  • Evaluation of preventive services from individual tests to population-wide programs.

Main Results:

  • Effective screening regimens do not always translate to effective screening programs.
  • Measures of effectiveness can vary significantly across different subgroups and real-world settings.
  • Regimen and program effectiveness measures address distinct scientific and policy inquiries.

Conclusions:

  • Differentiating regimen and program effectiveness is vital for accurate interpretation of CER findings.
  • Standardized measures and a common lexicon enhance communication and understanding in preventive services research.
  • Clearer measures support informed decision-making for patients, providers, and policymakers in disease prevention.